Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

21.08USD
24 May 2019
Change (% chg)

$0.32 (+1.54%)
Prev Close
$20.76
Open
$20.82
Day's High
$21.90
Day's Low
$20.82
Volume
27,373
Avg. Vol
18,000
52-wk High
$53.14
52-wk Low
$19.33

About

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2,... (more)

Overall

Beta: --
Market Cap(Mil.): $934.81
Shares Outstanding(Mil.): 44.35
Dividend: --
Yield (%): --

Financials

  AUTL.OQ Industry Sector
P/E (TTM): -- 93.20 35.48
EPS (TTM): -- -- --
ROI: -- 7.47 11.75
ROE: -- 7.94 16.52

Earnings vs. Estimates